
2026-04-09
Gawo 4 la khansa ya chiwindi, yomwe imadziwikanso kuti metastatic hepatocellular carcinoma, imayimira mtundu wapamwamba kwambiri wa matenda omwe khansa yafalikira ku ziwalo zakutali kapena ma lymph nodes. Mu 2026, njira zamankhwala ku China zidasintha kwambiri, zikusintha kuchoka ku chisamaliro chokhazikika kupita kumankhwala ankhanza omwe amaphatikiza ma immunotherapy, othandizira omwe akuwunikiridwa, komanso chithandizo chamakono cha ma cell. Zomwe zilipo pano zikuwonetsa kuti kupulumuka kwapakatikati kwa odwala a siteji 4 ku China kwachokera kuzaka zosakwana miyezi 12 mpaka pafupifupi miyezi 18-24, pomwe ena omwe adapulumuka kwa nthawi yayitali akupitilira zaka zisanu chifukwa cha kuvomereza kwatsopano kwa mankhwala ndi mwayi woyesa kuchipatala.
Gawo 4 la khansa ya chiwindi imadziwika ndi kufalikira kwa maselo owopsa kupitirira chiwindi kupita ku ziwalo zina za thupi, monga mapapu, mafupa, kapena ma lymph nodes akutali. M'mbuyomu, matendawa anali ndi chiyembekezo chowopsa chokhala ndi njira zochepa zochizira. Komabe, mawonekedwe azachipatala mu 2026 asintha kwambiri, makamaka mkati mwa gawo la oncology ku China.
Tanthauzo la gawo 4 limakhalabe losasinthika padziko lonse lapansi, koma njira yoyendetsera ku China tsopano ikuthandizira kuphatikiza kwapadera kwamankhwala opangidwa kunyumba ndi miyezo yodziwika padziko lonse lapansi. Cholinga chasinthira ku "mankhwala otembenuzidwa," pomwe cholinga chake ndikuchepetsa zotupa mokwanira kuti milandu yomwe inali yosagwira ntchito ikhale yoyenera kuchitidwa opaleshoni kapena kuchotsedwa kwawoko.
Odwala omwe amapezeka panthawiyi nthawi zambiri amakhala ndi zizindikiro zazikulu, kuphatikizapo jaundice, ascites, kutopa kwambiri, ndi ululu. Ngakhale zovuta izi, kuphatikiza kwa magulu amitundu yambiri (MDT) m'zipatala zapamwamba za China kumatsimikizira kuti wodwala aliyense amalandira kuyesedwa kwaumwini. Njira yonseyi simangoganizira za kuchuluka kwa chotupa komanso ntchito yachiwindi, yomwe ndi yofunika kwambiri kwa anthu omwe ali ndi chiwopsezo chachikulu cha Hepatitis B.
Chaka cha 2026 ndi nthawi yofunikira kwambiri pakuchiza khansa ya chiwindi ku China, motsogozedwa ndi kuvomerezedwa ndi mabungwe angapo oyambira komanso kukonzanso kwamankhwala omwe alipo. Bungwe la National Medical Products Administration (NMPA) lafulumizitsa njira yovomerezera mankhwala omwe akuyang'ana njira zina zamagulu, zomwe zimapereka chiyembekezo chatsopano kwa odwala omwe ali mu gawo 4.
Chochititsa chidwi kwambiri ndi kukhazikitsidwa kwa njira za "Target plus Immune" (T + I). Kuphatikizika kumeneku kumaphatikiza ma tyrosine kinase inhibitors (TKIs) okhala ndi ma immune checkpoint inhibitors (ICIs) kuti nthawi imodzi aletse zizindikiro za kukula kwa chotupa ndikuyambitsa chitetezo chamthupi cha wodwalayo kuti chiwukire maselo a khansa. Njira yapawiri imeneyi yakhala mulingo watsopano wa chisamaliro chamankhwala oyamba.
Kuphatikiza apo, China yawona kukwera kwa biologics zanyumba zomwe zimapereka mphamvu zofananira ndi mtundu wapadziko lonse lapansi koma pamtengo wopezeka. Zatsopano zakunyumba izi zikukonzanso njira yamankhwala, kupereka njira zina kwa odwala omwe sangalole miyezo yapadziko lonse lapansi kapena apita patsogolo.
Chimodzi mwazofunikira kwambiri mu 2025 ndikupitilira mu 2026 ndikuvomerezedwa kwa Lenvatinib kuphatikiza Pembrolizumab ndi Transarterial Chemoembolization (TACE). Njira yowopseza katatu iyi, yotsimikiziridwa ndi kafukufuku wa LEAP-012, ikuyimira dziko lonse lapansi pakuphatikiza ma radiology ndi njira zochiritsira zomwe zimayang'aniridwa ndi chitetezo chamthupi.
Regimen iyi imapangidwira kuti ikhale yosasinthika yopanda metastatic hepatocellular carcinoma, koma mfundo zake zimagwiritsidwa ntchito kwambiri ku oligometastatic stage 4 milandu kuti athetse matenda a intrahepatic pamene akuyang'anira kufalikira kwakutali. Deta ikuwonetsa kupulumuka kwa miyezi 24 ya 75%, kuwongolera kwakukulu kuposa ma benchmark am'mbuyomu.
Makinawa akuphatikizapo TACE kudula magazi ku chotupa cha chiwindi, Lenvatinib inhibiting angiogenesis kuletsa mapangidwe atsopano a mitsempha yamagazi, ndi Pembrolizumab kumasula T-maselo kuti achotse ma cell a khansa otsalira. Zotsatira za synergistic izi zapangitsa kuti pakhale kupulumuka kwapakatikati kwa miyezi 14.6 m'mayesero azachipatala.
Finotonlimab, yopangidwa ndi Sinocelltech, idatuluka ngati yosintha masewera koyambirira kwa 2025 ndipo tsopano ndimwala wapangodya wa chithandizo cha siteji 4 ku China. Idavomerezedwa mu February 2025 chifukwa chosachiritsika kapena metastatic hepatocellular carcinoma, choletsa ichi cha PD-1 chimagwiritsidwa ntchito limodzi ndi bevacizumab biosimilar.
Deta yachipatala imasonyeza chiwerengero cha kuyankha kwa cholinga (ORR) cha 33%, chokwera kwambiri kuposa 4% yomwe imawoneka m'magulu olamulira omwe akulandira chisamaliro chokhachokha. Chofunika kwambiri, kupulumuka kwapakatikati kunafika miyezi 22.1, kuchepetsa chiopsezo cha imfa ndi 40% poyerekeza ndi mkono wolamulira.
Kufikika kwa Finotonlimab kwakulitsidwa ndikuphatikizidwa m'madongosolo a inshuwaransi mdziko lonse m'maboma ambiri, zomwe zimapangitsa kuti chitetezo cham'tsogolochi chitheke kwa anthu ambiri. Mbiri yake yachitetezo ndiyabwino, yokhala ndi zotsatira zowongolera zomwe zimalola odwala kukhala ndi moyo wabwino panthawi ya chithandizo.
Kuphatikiza kwa Nivolumab ndi Ipilimumab, komwe nthawi zambiri kumadziwika kuti "O+Y" regimen, kunavomerezedwa ku China mu Marichi 2025 kuti alandire chithandizo choyambirira cha hepatocellular carcinoma. Kutsekereza kwapawiri kumeneku kumatsata njira zonse za PD-1 ndi CTLA-4, zomwe zimapereka njira yamphamvu yoyambitsa chitetezo chamthupi.
Njirayi ndiyothandiza makamaka kwa odwala omwe ali ndi chotupa chachikulu kapena omwe adalephera kulandira chithandizo cham'mbuyomu cha TKI. Kukhazikika kwa kuyankha ndi "O + Y" ndizodziwikiratu, ndi kagawo kakang'ono ka odwala omwe amakhala ndi moyo wautali kupitilira zaka zitatu, zomwe zimasowa mu gawo 4 khansa ya chiwindi m'mbiri.
Ngakhale mbiri ya kawopsedwe ikhoza kukhala yayikulu chifukwa cha zovuta zokhudzana ndi chitetezo chamthupi, kuwongolera mosamala ndi akatswiri odziwa za oncologist kumalola odwala ambiri kuti apindule kwambiri. Regimen tsopano ikupezeka m'zipatala zoyambira limodzi m'mizinda yayikulu yaku China monga Beijing, Shanghai, ndi Guangzhou.
Kumvetsetsa ziwerengero za kupulumuka ndikofunikira kwa odwala ndi mabanja omwe ali ndi matenda a stage 4. Ngakhale mbiri yakale idapereka chithunzi chodetsa nkhawa, kuphatikiza kwamankhwala amakono mu 2026 kwalembanso nkhaniyo. Kupulumuka sikumayesedwanso m'miyezi yokha koma kumawonjezeka m'zaka za odwala omvera.
Ndikofunika kusiyanitsa pakati pa kupulumuka kwapakati ndi kupulumuka kwa nthawi yayitali. Kupulumuka kwapakatikati kumayimira pakati pomwe theka la odwala amakhala nthawi yayitali ndipo theka amakhala wamfupi. Komabe, "mchira" wa mphira wopulumuka ukukulirakulira, kutanthauza kuti odwala ambiri akukhala opulumuka kwa nthawi yayitali.
Zomwe zimayambitsa milingo imeneyi ndi monga kukula kwa metastasis, kusungidwa kwa chiwindi (chiwerengero cha Mwana-Pugh), momwe amagwirira ntchito, komanso kuyankha chithandizo choyambirira. Odwala omwe ali ndi chiwindi cholipiridwa bwino komanso kufalikira kochepa kwa metastatic kumakhala bwino kwambiri.
Ulendo wa wodwala aliyense ndi wapadera. Kukhalapo kwa kachilombo ka Hepatitis B (HBV) kumafuna kuwongolera mwamphamvu kwa antivayirasi kuti apewe kuyambiranso panthawi ya immunotherapy, zomwe zitha kusokoneza ntchito ya chiwindi. Mosiyana ndi izi, kupondereza kwa HBV kogwira mtima kumatha kusintha zotsatira zonse.
Malo a metastases amathandizanso. Ma metastases a mafupa angafunike ma radiation kuti athetse ululu, pomwe ma metastases am'mapapo amatha kukhala ovomerezeka kumankhwala am'deralo ngati chotupa chachikulu cha chiwindi chikuwongoleredwa. Odwala omwe ali ndi machitidwe abwino (ECOG 0-1) amalekerera kuphatikizika mwaukali bwino ndipo motero amapeza zotsatira zabwino kwambiri za kupulumuka.
Kuwunika pafupipafupi komanso kuzindikira koyambirira kwa matendawa kumathandizira kusintha kwanthawi yake kumankhwala amzere wachiwiri, kukulitsa kupulumuka. Kupezeka kwa mizere ingapo yamankhwala othandiza mu 2026 kumatanthauza kuti kuzindikirika kwa siteji 4 sikungomaliza gawo limodzi koma ulendo wokhazikika wokhala ndi njira zingapo zomwe zingatheke.
Mbali yazachuma ya chithandizo cha khansa ndizovuta kwambiri kwa odwala. Mu 2026, mtengo wa chithandizo cha khansa ya chiwindi ku China udayenda bwino chifukwa cha zomwe boma likuchita, kugula zinthu motengera kuchuluka kwa zinthu (VBP), komanso kukulitsidwa kwa inshuwaransi. Komabe, ndalama zimatha kusiyanasiyana kutengera mtundu womwe wasankhidwa komanso gawo lachipatala.
Nthawi zambiri, mankhwala apakhomo ndi otsika mtengo kuposa anzawo ochokera kunja, ndipo njira zambiri zochiritsira zatsopano zakambitsirana mu National Reimbursement Drug List (NRDL). Kuphatikizikaku kumachepetsa kwambiri ndalama zomwe zili m'thumba kwa odwala omwe ali ndi inshuwaransi, zomwe zimapangitsa kuti chisamaliro chapamwamba chifike kwa anthu apakatikati.
Kwa anthu opanda inshuwaransi kapena omwe akufuna chithandizo choyesera chosabwezeredwa, ndalama zimakhalabe zokulirapo. Ndikofunikira kuti odwala akambirane za kawopsedwe azachuma ndi othandizira awo azaumoyo kuti apeze mgwirizano pakati pa kuchita bwino ndi kukwanitsa.
| Njira Yamankhwala | Chiyerekezo Chamtengo Wapachaka (CNY) | Momwe Inshuwaransi Yothandizira |
|---|---|---|
| Lenvatinib (Yapakhomo/Yachibadwa) | 15,000 - 30,000 | Chophimba Kwambiri (NRDL) |
| Lenvatinib (Original Brand) | 60,000 - 80,000 | Ophimbidwa Mwapang'ono |
| Finotonlimab + Bevacizumab Biosimilar | 40,000 - 60,000 | Chophimba Kwambiri (NRDL) |
| Nivolumab + Ipilimumab | 150,000 - 250,000 | Zochepa/Zachigawo |
| Pembrolizumab (Zochokera kunja) | 100,000 - 140,000 | Ophimbidwa Mwapang'ono |
| Mayesero a Zachipatala a CAR-T | Zaulere mpaka Zotsika mtengo | Wodalira Mayesero |
Zindikirani: Mitengo ndi yongoyerekeza ndipo ingasinthidwe malinga ndi mitengo yazipatala, mfundo za m'madera, ndi zofunikira za mlingo. Kuphatikizidwa kwa mankhwala mu NRDL nthawi zambiri kumabweretsa kutsika kwa mitengo mpaka 60-70% poyerekeza ndi mitengo yandandanda.
Ogwira ntchito m'matauni komanso ma inshuwaransi akuchipatala omwe amakhala ku China tsopano amapereka chithandizo choyamba cha khansa ya chiwindi. Odwala akuyenera kutsimikizira mfundo zawo ndi mabungwe achitetezo amderali. Kuphatikiza apo, makampani opanga mankhwala nthawi zambiri amapereka Mapulogalamu Othandizira Odwala (PAPs) omwe amapereka Mlingo waulere pambuyo pogula zinthu zambiri zolipiridwa.
Kwa iwo omwe akukumana ndi mavuto azachuma, maziko achifundo ndi ndalama zothandizira kuchipatala zingapereke chithandizo chowonjezera. Kuyenda pazithandizozi nthawi zambiri kumafuna kuthandizidwa ndi wogwira ntchito m'chipatala kapena woyang'anira milandu wodzipereka, ntchito yomwe imafala kwambiri m'malo akuluakulu a oncology.
Kupitilira mankhwala azikhalidwe, 2026 ikuwona China ikutsogola mu ma immunotherapies amtundu wa zotupa zolimba, makamaka khansa ya chiwindi. Chimeric Antigen Receptor T-cell (CAR-T) therapy, yomwe idangopezeka kokha ku khansa yamagazi, ikuwonetsa lonjezo lodabwitsa mu hepatocellular carcinoma kudzera m'mayesero azachipatala.
Cholinga chachikulu cha mankhwalawa mu khansa ya chiwindi ndi Glypican-3 (GPC3), antigen yowonetsedwa kwambiri pama cell a khansa ya chiwindi koma kulibe m'matenda ambiri abwinobwino. Izi zimachepetsa kawopsedwe komwe kamafuna, zomwe zimadetsa nkhawa kwambiri pakukula kolimba kwa chotupa cha CAR-T.
Makampani angapo achi China komanso mabungwe azamaphunziro asayansi ayambitsa mayeso owunika ma cell a CAR-T omwe akutsata GPC3. Kafukufuku woyambirira akuwonetsa kuti gawo la odwala omwe adalandirapo chithandizo kwambiri 4 amapeza mayankho okhazikika, ena amakhala opanda khansa kwa zaka zingapo.
Ori-C101 ndiwoyimira woyimilira pantchitoyi, wopangidwa kuti athane ndi vuto la immunosuppressive chotupa cha khansa ya chiwindi. Mwa kuphatikiza madera ozindikiritsa apadera, mankhwalawa amathandizira kulimbikira ndikukula kwa maselo a CAR-T mkati mwa chotupacho.
M'mayesero oyambilira okhudza odwala omwe adalephera kutsata njira zingapo zachipatala, Ori-C101 adawonetsa kuchuluka kwa matenda a 90%. Chochititsa chidwi n'chakuti, ena adapindula pang'onopang'ono kwa zaka ziwiri, ndipo moyo wonse unayandikira zaka zitatu mwa anthu omwe ali ndi zotsatira zoipa m'mbiri.
Ulamuliro wa Ori-C101 nthawi zambiri umaphatikizapo kulowetsedwa kumodzi kudzera mumtsempha wa chiwindi, kupereka maselo osinthidwa mwachindunji ku chiwindi. Njira yoberekera yamtunduwu imakulitsa kuwonekera kwa chotupa pomwe imatha kuchepetsa zotsatira zoyipa monga cytokine release syndrome.
Kafukufuku wofalitsidwa m'zaka zaposachedwa akuwonetsa kuthekera kosintha kwamankhwalawa. Pali zochitika zolembedwa za odwala 4 omwe ali ndi vuto la mitsempha ndi ma metastases akutali omwe adapeza chikhululukiro chathunthu kutsatira chithandizo cha GPC3 CAR-T. Odwalawa akhala opanda matenda kwa zaka zisanu ndi ziwiri mpaka zisanu ndi zitatu, akuchiritsidwa bwino ku matenda awo.
Ngakhale kuti nthawi zambiri amangopezeka ku mayesero azachipatala, mwayi wopeza mankhwalawa ukukulirakulira. Malo akuluakulu a khansa ku Beijing, Shanghai, ndi Tianjin akulembera odwala mwachangu maphunziro a Phase II ndi III. Kwa odwala a siteji 4 omwe ali ndi zosankha zochepa, kulembetsa m'mayesero oterowo kumayimira njira yotheka komanso yopulumutsa moyo.
Kusankha njira yoyenera yothandizira khansa ya chiwindi ya siteji 4 kumaphatikizapo kuyeza mphamvu, zotsatira zake, mtengo, ndi zifukwa zomwe odwala amachitira. Kuyerekeza kotsatiraku kukuwonetsa njira zoyambira zomwe zikupezeka ku China mu 2026.
| Njira | Njira | Zabwino Kwambiri | Mfundo zazikuluzikulu |
|---|---|---|---|
| TKI + Immunotherapy | Imalepheretsa kukula kwa mitsempha yamagazi ndikuyambitsa chitetezo chamthupi | Mulingo woyamba kwa odwala ambiri | Kuchita bwino komanso kulekerera; zambiri ndi inshuwaransi. |
| Dual Immunotherapy (O+Y) | Imatchinga malo awiri oyendera chitetezo (PD-1 ndi CTLA-4) | Kuchulukirachulukira kwa chotupa kapena kupita patsogolo mwachangu | Kukhazikika kwamphamvu kwamayankhidwe koma chiopsezo chowonjezereka cha zotsatira zokhudzana ndi chitetezo chamthupi. |
| TACE + Systemic Therapy | Local chotupa kulamulira pamodzi zokhudza zonse mankhwala kanthu | Matenda a chiwindi omwe ali ndi metastasis yochepa | Amafuna ntchito yabwino ya chiwindi; invasive ndondomeko zofunika. |
| CAR-T Cell Therapy | Ma T-cell opangidwa mwachibadwa amalimbana ndi ma antigen enieni | Milandu yotsutsa kapena ofuna kuyesedwa kuchipatala | Kuthekera kwa chikhululukiro chakuya, chokhalitsa; pakali pano amangokhalira kuyesedwa. |
| Chithandizo Chabwino Kwambiri | Kusamalira zizindikiro ndi kuchepetsa ululu | Odwala omwe ali ndi vuto losachita bwino | Imayang'ana kwambiri pa moyo wabwino osati kuchepa kwa chotupa. |
Njira yopangira zisankho iyenera kukhala ndi gulu lamagulu osiyanasiyana. Zinthu monga kupezeka kwa mitsempha ya esophageal (yomwe imawonjezera chiopsezo chotaya magazi ndi bevacizumab) kapena matenda a autoimmune (omwe angatsutse immunotherapy) ayenera kuunika mosamala.
Kwa odwala omwe ali ndi matenda a chiwindi B, kuwonetsetsa kuti ma virus akuponderezedwa ndikofunikira musanayambe mankhwala aliwonse ochepetsa chitetezo chamthupi kapena chitetezo chamthupi. Kulephera kutero kungayambitse kulephera kwachiwindi. Chifukwa chake, chithandizo "chabwino" ndi chomwe chimagwirizana ndi momwe thupi limakhalira komanso momwe wodwalayo alili.
Kuyendera njira yazaumoyo ku China pagawo 4 la chithandizo cha khansa ya chiwindi kumafuna kukonzekera komanso chidziwitso. Kuchokera posankha chipatala choyenera kuti mumvetsetse ndondomeko yolembera mayesero a zachipatala, apa pali ndondomeko ya sitepe ndi sitepe.
Poganizira zovuta za khansa ya chiwindi ya siteji 4, kufunafuna lingaliro lachiwiri kumalimbikitsidwa kwambiri. Akatswiri osiyanasiyana angapereke malingaliro osiyanasiyana pa kuthekera kwa opaleshoni yotembenuza kapena kuyenera kwa mankhwala osakaniza. Zipatala zambiri zapamwamba ku China zimapereka chithandizo chamaganizidwe achiwiri, kuthandizira kupeza odwala ochokera kumadera akutali.
Chithandizo champhamvu cha khansa ya chiwindi cha siteji 4 chimabwera ndi zotsatirapo zambiri. Kuwongolera izi moyenera ndikofunikira kuti mukhale ndi moyo wabwino komanso kuti chithandizo chipitirire. Zomwe zimachitika nthawi zambiri zimaphatikizapo kutopa, kuchitapo kanthu kwa khungu la phazi lamanja, kuthamanga kwa magazi, kutsekula m'mimba, ndi zochitika zoyipa zokhudzana ndi chitetezo chamthupi.
Kuwongolera mwachidwi kumaphatikizapo kuyang'anitsitsa kuthamanga kwa magazi, kuyesa ntchito ya chiwindi, ndi ntchito ya chithokomiro. Kusamalira dermatological kwa matenda a phazi lamanja ndikusintha zakudya zazizindikiro za m'mimba kumatha kuchepetsa kwambiri kusapeza bwino.
Chisamaliro chapalliative sichiyenera kuwonedwa ngati chisamaliro chakumapeto kwa moyo koma monga gawo lofunikira paulendo wamankhwala kuyambira tsiku loyamba. Kuphatikiza kasamalidwe ka ululu, chithandizo chopatsa thanzi, komanso upangiri wamaganizidwe kumathandiza odwala kuthana ndi vuto lakuthupi komanso lamalingaliro la matendawa.
Tsogolo la chithandizo cha khansa ya chiwindi cha gawo 4 ku China likuwoneka ngati labwino. Kafukufuku akuyandikira kulunjika kolondola kwambiri, kuphatikiza njira zingapo, komanso chithandizo chamunthu payekha malinga ndi mbiri ya chibadwa. Kupambana kwazatsopano zapakhomo kukuwonetsa kuti China ipitiliza kukhala likulu la kafukufuku wa khansa ya chiwindi.
Zomwe zikubwera zikuphatikizapo kugwiritsa ntchito luntha lochita kupanga kulosera momwe angayankhire chithandizo, kupanga ma antibodies a bispecific, ndi kukonzanso kwa ma cellular therapy kuti agwirizane ndi ma antigen angapo panthawi imodzi. Kupititsa patsogolo uku kukufuna kusintha gawo 4 la khansa ya chiwindi kukhala matenda osatha omwe amatha kutha kwa odwala ambiri.
Pamene deta ikukula komanso odwala ambiri amapindula ndi machitidwe atsopanowa, maulendo opulumuka adzapitirizabe kusunthira mmwamba. Mgwirizano wapakati pa akatswiri amaphunziro, mafakitale, ndi boma ku China umapangitsa kuti pakhale chilengedwe champhamvu kuti chimasulire mwachangu zomwe asayansi apeza m'machitidwe azachipatala.
Kutsatizana kwa ma genomic kwa minofu ya chotupa kukukulirakulira, kulola madotolo kuzindikira masinthidwe enieni omwe angayankhe kumankhwala omwe akufuna. Njira yolondola yamankhwala iyi imawonetsetsa kuti odwala amalandira chithandizo chothandiza kwambiri cha biology yawo ya chotupa, kuchepetsa kawopsedwe kosafunikira.
Kuphatikiza apo, ma biopsies amadzimadzi (mayeso amagazi ozindikira chotupa cha DNA) akuwunikidwa ngati zida zodziwira msanga za kubwereza komanso kuwunika momwe chithandizo chamankhwala chikugwirira ntchito. Njira yosagwiritsa ntchito imeneyi ingathe kusintha momwe khansa ya m'chiwindi 4 imayendetsedwa, kulola kusintha kwamphamvu kwamankhwala.
Mu 2026, malo a Gawo 4 la khansa ya chiwindi chithandizo ku China chasintha kwambiri. Anapita masiku pamene matenda amatanthauza chisamaliro chanthawi yomweyo. Masiku ano, zida zochiritsira zamphamvu, kuphatikiza zophatikizira za TKI-immunotherapy, zopambana zapakhomo monga Finotonlimab, komanso mayeso apamwamba a CAR-T - zimapereka chiyembekezo chenicheni chakukhala ndi moyo wautali komanso moyo wabwino.
Ndi nthawi zopulumuka zapakatikati zomwe zikupitilira zaka ziwiri komanso gulu lomwe likukulirakulira la opulumuka kwa nthawi yayitali, mawonekedwe ake ndi owala kuposa kale. Ngakhale zovuta zokhudzana ndi mtengo ndi mwayi zikupitilirabe, kuyesetsa kwadongosolo lachipatala ku China kuti aphatikize zatsopano ndi zothekera kupangitsa kuti chithandizo chopulumutsa moyochi chipezeke.
Kwa odwala ndi mabanja, chofunikira ndikufunafuna chithandizo ku malo apadera, kufufuza njira zonse zomwe zilipo kuphatikizapo mayesero a zachipatala, ndi kuyankhulana momasuka ndi opereka chithandizo chamankhwala. Ulendo wokhala ndi khansa ya pachiwindi 4 ndizovuta, koma ndikupita patsogolo kwa 2026, ndi ulendo wodzaza ndi mwayi womwe sunachitikepo.